Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ICON PLC (ICLR : NSDQ)
 
 • Company Description   
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

Number of Employees: 40,100

 
 • Price / Volume Information   
Yesterday's Closing Price: $185.27 Daily Weekly Monthly
20 Day Moving Average: 902,298 shares
Shares Outstanding: 76.57 (millions)
Market Capitalization: $14,185.57 (millions)
Beta: 1.24
52 Week High: $203.91
52 Week Low: $66.57
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 6.54% 7.66%
12 Week 11.93% 9.19%
Year To Date 1.67% -9.10%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN
-
DUBLIN 18,L2 00000
IRL
ph: 353-1291-2000
fax: 353-1247-6260
None http://www.iconplc.com
 
 • General Corporate Information   
Officers
Steve Cutler - Chief Executive Officer and Director
Ciaran Murray - Chair and Director
Barry Balfe - Chief Operating Officer
Nigel Clerkin - Chief Financial Officer
Ronan Murphy - Lead Independent Director

Peer Information
ICON PLC (CHCR)
ICON PLC (ESRX)
ICON PLC (MYDP)
ICON PLC (COR)
ICON PLC (GBCS)
ICON PLC (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G4705A100
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 10/27/26
Share - Related Items
Shares Outstanding: 76.57
Most Recent Split Date: 8.00 (2.00:1)
Beta: 1.24
Market Capitalization: $14,185.57 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $2.60 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $9.55 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 1.62% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 10/27/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 19.40
Trailing 12 Months: 19.28
PEG Ratio: 11.97
Price Ratios
Price/Book: 1.51
Price/Cash Flow: 10.99
Price / Sales: 1.72
EPS Growth
vs. Year Ago Period: -25.63%
vs. Previous Quarter: 5.86%
Sales Growth
vs. Year Ago Period: 2.29%
vs. Previous Quarter: 1.45%
ROE
09/30/26 - -
06/30/26 - 8.02
03/31/26 - 8.73
ROA
09/30/26 - -
06/30/26 - 4.56
03/31/26 - 4.96
Current Ratio
09/30/26 - -
06/30/26 - 0.95
03/31/26 - 1.14
Quick Ratio
09/30/26 - -
06/30/26 - 0.95
03/31/26 - 1.14
Operating Margin
09/30/26 - -
06/30/26 - 9.04
03/31/26 - 9.94
Net Margin
09/30/26 - -
06/30/26 - 3.99
03/31/26 - 5.35
Pre-Tax Margin
09/30/26 - -
06/30/26 - 1.31
03/31/26 - 2.42
Book Value
09/30/26 - -
06/30/26 - 122.48
03/31/26 - 121.47
Inventory Turnover
09/30/26 - -
06/30/26 - -
03/31/26 - -
Debt-to-Equity
09/30/26 - -
06/30/26 - 0.23
03/31/26 - 0.31
Debt-to-Capital
09/30/26 - -
06/30/26 - 18.37
03/31/26 - 23.56
 

Powered by Zacks Investment Research ©